Ecog-acrin Cancer Research Group

This study tested whether giving two targeted drugs (encorafenib and binimetinib) before surgery could help shrink tumors in patients with stage III melanoma that had spread to their lymph nodes. The goal was to see if this approach could lead to a complete disappearance of cance…

This study tested whether adding the drug hydroxychloroquine to the standard two-drug treatment (dabrafenib and trametinib) could better control advanced melanoma that has a specific genetic change (BRAF V600E/K). It aimed to see if the three-drug combo could delay cancer growth …

This study tested two drug combinations to treat severe lung inflammation (pneumonitis) in cancer patients. The inflammation was a serious side effect of certain cancer immunotherapies that didn't improve with standard steroid treatment. Researchers compared infliximab with intra…